AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Regulation FD Disclosure

0

AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

On or about September 5, 2017, the Company posted on its website (at http://Investors.Avadel.com) a slide presentation intended to be used for investor presentations. That slide presentation has been revised to include an updated slide #19 and such slide presentation (as revised) has been posted on the Company's website and is furnished as Exhibit 99.1 to this Amendment.

The information in Item 7.01 of this current report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section, nor shall such information be incorporated by reference into any registration statement or other filing to the Securities Act of 1933, except as may be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1

Revised Slide Presentation of Avadel Pharmaceuticals plc dated as of September 6, 2017


AVADEL PHARMACEUTICALS PLC Exhibit

To view the full exhibit click here